| Gene symbol | CD5 | Synonyms | LEU1, T1 | Type of gene | protein-coding |
| Chromosome | 11 | Map location | 11q12.2 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | CD5 molecule | ||||
| GTO ID | GTC3218 |
| Trial ID | NCT05596266 |
| Disease | T-Cell Acute Lymphoblastic Leukemia |
| Altered gene | CD5 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD5 CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | CD5 CAR-T Therapy for Refractory/Relapsed CD5+ T-cell Acute Lymphoblastic Leukemia |
| Year | 2022 |
| Country | China |
| Company sponsor | Xuanwu Hospital, Beijing |
| Other ID(s) | 202001 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||
|
|||||||